Apogee Therapeutics, Inc. ($APGE)
Filing Information
| Accession Number | 0001140361-26-035609 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
1,918,005
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 3, 2026 | Sale to Issuer | 920,941 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 3, 2026 | Sale to Issuer | 387,012 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 3, 2026 | Sale to Issuer | 357,036 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 3, 2026 | Sale to Issuer | 253,016 | โ | โ | 0 | Direct | โ | View Details |